Dr. Katherine Emily Promer, MD

Dr. Promer practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Promer's NPI, 1306280607, was assigned on April 18, 2013. Dr. Promer graduated from University of Toledo College of Medicine and Life Sciences in 2013. Dr. Promer holds California license A131952.

Dr. Promer's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Promer's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Promer is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Promer to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Promer practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Promer's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Promer is board certified in hiv specialist by the AAHIVM. Dmand AI has Dr. Promer's licenses on file in 2 states: California and New Hampshire.

Dmand AI lists hiv/aids among the conditions Dr. Promer treats.

CMS data shows 150 Medicare services from Dr. Promer across 5 procedure codes in 2024, for 95 Medicare patients. Medicare paid $12,521 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Promer in 2024. The largest group is 65 to 74, with 44 patients. 64% of them have high blood pressure, and 64% have high cholesterol. 67% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Promer's median patient age at 53, with 16% women.

In 2024, Dr. Promer wrote 1,662 Medicare Part D claims for 120 patients. 63% of them were for generic drugs. CMS names the drug for 1,225 of them, across 42 drugs with 11 or more claims each, at $1,488,591 in total drug cost. In 2023, CMS named 768 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Promer for performance year 2024, reported as part of a group. Dr. Promer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Promer as offering telehealth.

Dmand AI links 6 papers to Dr. Promer, published from 2018 to 2024. The most frequent topics are HIV Infections. Dr. Promer's most frequent co-authors are Sharon L. Reed, MD, Darcy Alison Wooten, MD and Rosa Mercedes Andrade, MD.

CMS Open Payments shows 36 general payments to Dr. Promer from 5 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 53% of the total. Gilead Sciences, Inc. paid the most, $955.

Dr. Promer graduated from University of Toledo College of Medicine and Life Sciences in 2013. Dr. Promer is a member of IDSA.

Dr. Promer is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.